| Ekkehard Schütz |
Dr. Ekkehard Schütz is a Chief Science Officer at OncoCyte Corp. and a Chief Executive Officer & Chief Medical Officer at Chronix Biomedical, Inc. He received his doctorate degree from the University of Gottingen. |
| Padma Sundar |
Padma Sundar is currently the Director at Smart Health Diagnostics Co. and the Chief Commercial Officer at OncoCyte Corp. She previously worked as the Senior Director-Oncology at Affymetrix, Inc., the Director-Marketing at Guardant Health, Inc., the Senior Director at Roche Sequencing Solutions, Inc., and the Vice President-Strategy & Market Access at Cellmax, Inc. She completed her undergraduate degree at the University of Delhi and holds an MBA from the University of California. |
| Joshua Riggs |
Mr. Joshua Riggs is a President, Chief Executive Officer & Director at OncoCyte Corp. He is on the Board of Directors at OncoCyte Corp. Mr. Riggs was previously employed as a Principal by Bethesda Group LLC. |
| Yuh-Min Chiang |
Yuh-Min Chiang is currently the Chief Technology Officer at OncoCyte Corp. He previously held the position of Chief Technology Officer at Alveo Technologies, Inc. |
| Andrew Arno |
Andrew Arno is the founder of Unterberg Capital LLC, which was founded in 2009. He held the title of Vice Chairman & Chief Marketing Officer from 2009 to 2012. Mr. Arno's current job(s) include being the Chairman, CEO, CFO & Secretary at ComHear, Inc. since 2017, Chairman at OncoCyte Corp. since 2015, Independent Director at Smith Micro Software, Inc. since 2011, Independent Director at 22nd Century Group, Inc. since 2023, Director at Independa, Inc., Treasurer & Director at The Jewish Community Center in Manhattan, Inc., and Director at New York Service for the Handicapped. Mr. Arno's former job(s) include being the Chairman & Chief Executive Officer at C. E. Unterberg, Towbin Advisors LP, Chairman & Chief Executive Officer at C. E. Unterberg, Towbin, Inc. from 1990 to 2007, Chairman & Chief Executive Officer at Collins Stewart LLC from 2007 to 2008, Vice Chairman at Merriman Holdings, Inc. from 2009 to 2011, Vice Chairman & Head-Equity Capital Markets at Merriman Capital, Inc., Vice Chairman at Chardan Capital Markets LLC from 2013 to 2015, Chairman at Collins Stewart LLC (Investment Management) from 2007 to 2008, Vice Chairman at Bradley Woods & Co. Ltd. from 2013 to 2015, Vice Chairman at The Special Equities Group LLC, Managing Director at Emerging Growth Equities Ltd. from 2013 to 2015, Independent Director at Asterias Biotherapeutics, Inc. from 2014 to 2019, Vice President at Lehman Brothers, Inc. from 1987 to 1989, President at Loewen, Ondaatje, McCutcheon USA Ltd., Vice President at L. F. Rothschild, Unterberg, Towbin, Inc. from 1981 to 1986, Vice President at Sabr Group, Inc. from 2013 to 2015, and President at Lomusa Ltd. from 2009 to 2012. Mr. Arno's education history includes undergraduate studies at George Washington University. |
| Andrew J. Last |
Dr. Andrew J. Last is a Chief Operating Officer & Executive Vice President at Bio-Rad Laboratories, Inc. and an Independent Director at OncoCyte Corp. He is on the Board of Directors at OncoCyte Corp. Dr. Last was previously employed as a Chief Commercial Officer by Berkeley Lights, Inc., a Chief Operating Officer by Intrexon Corp., a Chief Operating Officer & Executive Vice President by Affymetrix, Inc., a Vice President-Global & Strategic Marketing by BD Biosciences, Systems & Reagents, Inc., a VP-Global Marketing & Strategic Planning by Becton, Dickinson & Co., a General Manager by PharMingen, a Vice President & General Manager by Applera Corp., a Vice President & GM-Gene Expression Business by Applera Corp., a Director-Worldwide Business by Monsanto AG Co., and a Director-Ortho Home & Garden by The Solaris Group. He received his undergraduate degree from the University of Leicester, a graduate degree from Cranfield University and a doctorate degree from Cranfield University. |
| Alfred Dennis Kingsley |
Mr. Alfred D. Kingsley is an Executive Chairman at BioTime Asia Ltd., an Executive Chairman at ES Cell International Pte Ltd., an Executive Chairman at OrthoCyte Corp., an Independent Director at OncoCyte Corp., a Chairman at Lineage Cell Therapeutics, Inc., a General Partner at Greenway Partners LP and a President at Greenbelt Corp. He is on the Board of Directors at Cell Cure Neurosciences Ltd., ReCyte Therapeutics, Inc., OncoCyte Corp. and Ascendance Biotechnology, Inc. Mr. Kingsley was previously employed as an Independent Director by Asterias Biotherapeutics, Inc., a Chairman by AgeX Therapeutics, Inc., and a Senior Vice President by Icahn & Co., Inc. He also served on the board at LifeMap Sciences, Inc. He received his undergraduate degree from The Wharton School of the University of Pennsylvania and a graduate degree from New York University School of Law. |
| Louis E. Silverman |
Mr. Louis E. Silverman is a Lead Independent Director at OncoCyte Corp. and a Chairman & Chief Executive Officer at Hicuity Health. He is on the Board of Directors at OncoCyte Corp., PatientPay, Inc. and Central Maine Healthcare Corp. Mr. Silverman was previously employed as a Chairman by STAAR Surgical Co., a Chairman by Comarco, Inc., an Independent Director by Questcor Pharmaceuticals, Inc., a Chief Executive Officer by Marina Medical Billing Services, Inc., a Chief Executive Officer-LifeComm Division by QUALCOMM, Inc., a President & Chief Executive Officer by Quality Systems, Inc., and a Chief Operating Officer by CorVel Corp. He also served on the board at Senior Home Care, Inc. He received his undergraduate degree from Amherst College and an MBA from Harvard Business School. |
